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In volumetric modulated arc therapy (VMAT) for prostate cancer, a positional and rotational 
error correction is performed according to the position and angle of the prostate. The 
correction often involves body leaning, and there is concern regarding variation in the dose 
distribution. Our purpose in this study was to evaluate the impact of body pitch rotation on the 
dose distribution regarding VMAT. Treatment plans were obtained retrospectively from eight 
patients with prostate cancer. The body in the computed tomography images for the original 
VMAT plan was shifted to create VMAT plans with virtual pitch angle errors of ±1.5 and ±3 
degrees. Dose distributions for the tilted plans were recalculated with use of the same beam 
arrangement as that used for the original VMAT plan. The mean value of the maximum dose 
differences in the dose distributions between the original VMAT plan and the tilted plans was 
2.98 ± 0.96%. The value of the homogeneity index for the planning target volume (PTV) had 
an increasing trend according to the pitch angle error, and the values of the D95 for the PTV 
and D2ml, V50, V60 and V70 for the rectum had decreasing trends (p<0.05). However, there was 
no correlation between differences in these indexes and the maximum dose difference. The 
pitch angle error caused by body leaning had little effect on the dose distribution, in contrast, 
the pitch angle correction reduced the effects of organ displacement and improved these 
indexes. Thus, the pitch angle setup error in VMAT for prostate cancer should be corrected. 
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Many patients with prostate cancer are treated with precision irradiation techniques such as 
intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). 
IMRT and VMAT require high-precision patient setup to ensure accurate radiation dose 
delivery. However, positional uncertainties regarding the prostate exist as a result of 
variations in the inter- and intra-fractional position. Schallenkamp et al. [1] evaluated the 
relationship between the position of a gold marker implanted in the prostate and that of the 
pelvic bones. They found that the position of the prostate was not related to the position of the 
pelvic bones. Ghilezan et al. [2] found that the degree of prostate motion depended on the 
volume of feces in the rectum. In other words, the prostate moves independently in the body, 
and its motion depends on the rectal volume.  
Prostate motion consists of translations and rotations. The translational positional error 
of the prostate during a treatment course or during a single treatment session has been 
assessed previously in many studies [3-6]. Rotational error has also been evaluated with use 
of an in-room computed tomography (CT) system [7]. The standard deviations of 
inter-fractional rotations around the lateral and superior-inferior axes were found to be 
approximately 8 degrees when measured with implanted markers. However, in measurements 
involving the contoured prostate in the CT images, the standard deviation of inter-fractional 
rotations around the lateral axis was reported to be approximately 10 degrees [7]. Hoogeman 
et al. [8] evaluated prostate motion with a view to reducing rotational motion effects, and that 
found that the rotation around the lateral axis was the largest of the rotations around the three 
coordinate axes. Thus, rotation around the lateral axis (referred to as pitch rotation) of a 
prostate should be of concern in high-precision radiotherapy. 
The effects of setup error, including rotational errors, on the dose distribution during 
commonly used radiation therapies have been evaluated for several body sites [9]. The 
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dosimetric effect of rotational setup errors concerning IMRT for head and neck cancer has 
also been evaluated [10]. Cranmer-Sargison reported the dosimetric impact of rotational error 
in three-dimensional conformal radiation therapy for prostate cancer [11]. Rotational errors 
around the lateral and anterior-posterior axes had a greater effect on the dose distribution than 
did the other types of rotation error. The impact of rotational error regarding the treatment of 
prostate cancer with VMAT has not yet been evaluated, and our preliminary study showed 
that pitch angle error affected the dose distribution more than did the other angle errors [12]. 
For avoiding this impact of rotational setup errors, adding additional margins for rotational 
setup errors to clinical target volume (CTV) is a solution, however, the calculation of the 
margin for rotational setup errors is very complicated, so that many institutions would not add 
such a margin to CTVs[13].    
McNair et al. [14] compared setup error correction methods by using the bony 
anatomy and gold markers implanted in the prostate. Corrections made by means of the gold 
markers resulted in a more accurate setup than did those made based on the bony anatomy. 
Presently, six-degrees-of-freedom robotic couches are used for setup error correction. Such a 
couch can lean by approximately ±3 degrees. When the rotational error regarding the prostate 
is corrected with a robotic couch, the surface of the body will lean because the prostate moves 
independently of the patient’s body in almost all cases. In such cases, there is concern that this 
lean might change the dose distribution in the body.  
Deformation of the rectum as a result of volume change should affect the dose 
distribution and the dose to the organs more than does the setup error alone. Ghilezan et al. [2] 
found that prostate motion would be produced by the deformation of the rectum; this means 
that the impact of rectum deformation on the dose distribution could include the impact of 
prostate motion. It is important to evaluate the impact of each of the factors. However, certain 
categorization or quantitation of the deformation is not an easy task. We focused on the 
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impact of prostate motion, especially pitch angle rotation. 
In summary, pitch angle errors that involve rotation around the lateral axis constitute 
the major rotational error associated with cancer treatment of prostate, and its effects on the 
dose distribution of VMAT treatment plans have not been evaluated. Although rotational error 
can be corrected with a six-degrees-of-freedom robotic couch, there is concern about varying 
the dose distribution as a result of body surface leaning.   
In the present study, we evaluated the impact of the pitch angle error with regard to the 
dose distribution in VMAT, including the effects of body leaning associated with pitch angle 
error correction.  
 
2. MATERIALS AND METHODS 
VMAT plans from eight cases involving local prostate cancer were evaluated retrospectively 
in this study. The median age of the patients was 67 (range, 60–83) years, and the clinical 
stages ranged from stage II to stage IV. Two of the eight patients had received treatment 
involving a combination of permanent implantation of 125-I seeds and VMAT for the prostate. 
Three patients were treated with a combination of whole pelvis irradiation and VMAT, and the 
remaining patients were treated with VMAT with irradiation restricted to the prostate only. 
The patient position was prone in six cases and supine in the other two. The number of 
fractions administered ranged from 12 to 38, and the total doses delivered ranged from 24 to 
76 Gy. For all treatment plans, the prostate was contoured as the CTV and the CTV to 
planning target volume (PTV) margin was 0.5 cm on the posterior side of the prostate and 0.8 
cm on the other sides. The isocenter was placed at the center of the PTV. This study was 
approved by the institutional review board for the collection and use of patient treatment 
planning data. 
Several studies have simulated the rotational setup errors by arrangement of the beam 
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alignment [9-11]. This is possible for a treatment plan with fixed beams such as a fixed beam 
IMRT plan. However, a VMAT plan has a rotating beam, so that the patient body in the CT 
images has to be rotated. Additionally, if the body has to be rotated three-dimensionally, an 
interpolation process is necessary for the production of the CT slice images. The interpolation 
process might make the volume of the contours such as the PTV and rectum vary. Thus, in the 
present study we shifted the body in the CT images according to the pitch angle. With this 
method, the contours are not deformed and the volume of the contours can be maintained for 
comparison. Then, the radiation treatment planning system (TPS; Monaco Ver. 4: Elekta, 
Crawley, UK) that we used can calculate the dose distribution without volume change of the 
contours, so that the dose and volume indexes for the tilted plan can be compared with those 
for the original one because the indexes are based on the same volume.  
For direct evaluation of the effect of body leaning, the prostate in the CT images 
should be rotated independently of the other anatomy. However, prostate rotation will result in 
the need for rectum or bladder deformation, and such deformation of the anatomy is not 
known. Anatomic structure deformation makes comparison of the dose to the target structure 
complicated because of the volume change. Therefore, we decided to discuss the effect of 
body leaning on the results obtained with this method.      
The CT images for all original VMAT plans were acquired with a Toshiba Aquirion 
L/B (Toshiba Medical Systems, Ohtawara, Japan) operating at 120 kV and 100 mA, with a 
3-sec rotation and a slice thickness of 2 mm. The CT image had a matrix size of 512 × 512 
and a field of view 40 cm in diameter. The VMAT plans were used for clinical treatment, and 
all patients completed their treatments.   
 A CT image set with a pitch angle error was created with the original CT image set 
used in patient treatment. The virtual pitch angle errors were ±1.5 and ±3 degrees based on the 
original VMAT plan. A maximum angle of ±3 degrees was selected because robotic couches 
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in hospitals can correct the angle setup error in that range. The direction of rotation is shown 
in Fig. 1. 
  For creating a CT image set with a pitch angle setup error, the body and all structures 
such as the PTV and the rectum in each CT image slice were moved up or down in the slice 
by distances d1 and d2 (Fig. 2), according to the pitch angle. The center of rotation was the 
isocenter. For moving the body up, several top rows equivalent to d1 of the CT image matrix 
were removed. Several top rows of the matrix were added for moving the body down. The 
structures were moved manually corresponding to the distance equivalent to d1 and d2 to fit 
the shifted body in each CT image. With use of this method, it was possible to maintain the 
volume.  
There was a difference in the superior-inferior (SI) direction between a position that 
was actually rotated and one shifted in a plane. Our tilted plans did not take into account this 
difference in the SI direction (Fig. 2). However, the distance between these two positions was 
not significantly large. The distance can be calculated as follows: 
 
)1(        , )cos1( θ−= de  
 
where e is the distance in the SI direction between the rotated and shifted positions in an 
image and d is the distance from the rotation center to a point that was rotated or shifted. θ  
is the pitch angle setup error. When d = 30 mm, e is 0.04 mm. The length of 30 mm was the 
average half length of the prostate in the SI direction in the current study, the length being 
about 60 mm. Even if d = 60 mm, e = 0.08 mm. That distance was smaller than the pixel size 
of the CT images. 
 A tilted plan was created by use of one of the CT image sets with a virtual pitch angle 
error and the same beam arrangements as those of the original plan, and the dose distribution 
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was recalculated for the tilted plan. Calculation of the dose distribution for all plans was 
performed with the use of the TPS. The dose distribution was computed by means of the 
Monte Carlo method, with a dose variance of 3% and a calculation grid size of 3 × 3 mm2, 
because these parameters were used clinically and the original plan had been calculated with 
the same parameters. The plan and its dose distribution, which was approved by a radiation 
oncologist, were treated as the reference so that the tilted plans could be calculated with use of 
the same parameter values.  
 The maximum differences in the dose between the dose distribution of the original 
plan and that of a tilted one were obtained. Dose distribution data were exported from the TPS 
to files in the digital information and communication in medicine extension for radiation 
therapy (DICOM-RT) format. The dose difference was calculated by subtracting of the dose 
data obtained from the DICOM-RT files of the original plan from the dose data of the tilted 
plan.  
 To compare the doses to normal tissues (rectum and bladder) and targets (CTV and 
PTV), we evaluated dose indexes for the targets and normal tissues and volume indexes for 
normal tissues on each plan. The dose indexes for the CTV and PTV were the homogeneity 
index (HI), median dose (Dmed), the dose at 95% volume (D95) and the dose at 2% volume 
(D2). Use of D2 as the maximum dose was recommended in the International Commission on 
Radiation Units and Measurements Report 83 [15]. The dose to the CTV and PTV was 
normalized by the total dose for each patient and was represented as a percentage based on the 
total dose. The range of total doses for the cases was 24–76 Gy. Several definitions of the HI 
are available. The HI that we used is defined as  
 








where D98 is the dose to a structure where 98% of the volume of the structure receives more 
than this dose, and D50 are the doses delivered to 50% of the volume of a structure. 
 The dose indexes and volume indexes for the rectum and bladder were Dmed and D2ml, 
and the volumes that received more than 40 Gy (V40), 50 Gy (V50), 60 Gy (V60), and 70 Gy 
(V70) were obtained. The D2ml is the dose to a volume of 2 ml of the rectum or the bladder. To 
calculate the dose and volume indexes for the bladder and rectum, we rescaled the prescribed 
dose for the plans as 76 Gy, and the dose indexes for the bladder and rectum were expressed 
in Gy. High-dose delivery to the rectum can cause bleeding, so that volumes with high-dose 
exposure such as the V60 and V70 are important indexes for prognosis regarding side effects. 
All dose and volume indexes were tested statistically with use of the Kruskal–Wallis test [16], 
which is a non-parametric method for testing differences among more than two groups; the 
significance of the trend for each of the dose and volume indexes that depended on the pitch 
angle error was confirmed by use of the Jonckheere–Terpstra test [17].  
Maximum dose differences between the dose distributions of the tilted plans and that of 
the original one were obtained, and differences of the dose or volume index values for the 
tilted plans from the corresponding value of the original plan was obtained. The correlation 
between the difference of the index values and the maximum dose differences was 
investigated. The indexes which demonstrated the statistical significance by the 
Jonckheere–Terpstra test were used for investigation of the correlation. 
 
3. RESULTS 
Results of the dose and volume index for CTV, PTV, bladder, and rectum are shown in Fig. 3, 
4, 5 and 6, respectively. There was no significant difference in the dose and volume indexes 
regarding the tilted plans at each pitch angle as determined by the Kruskal-Willis test (p > 
0.05). However, by the Jonckheere-Terpstra test, values for the D95 (p=0.036) for the PTV 
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(Fig. 4) and D2ml (p=0.015), V50 (p=0.037), V60 (p=0.030), and V70 (p=0.011) for the rectum 
(Fig. 6) had a significant decreasing trend according to the pitch angle error, and values for 
the HI (p=0.005) for the PTV (Fig. 4) had a significant increasing trend. 
The maximum dose difference was obtained by subtraction of each dose distribution 
for the original plan from that for the tilted one. In the front or back skin area, the subtracted 
dose was relatively higher/lower than the subtracted dose in the middle portion of the body; 
this was because the dose difference at these skin areas represented the difference between the 
dose to tissue and the dose to air. The dose differences in these skin areas were not included in 
the calculation of the maximum dose difference. The subtracted dose that represented the 
difference in the dose distribution of the −3 degrees tilted plan from that of the original one 
overlying the original CT image is shown in Fig. 7 as an example. This case had the largest 
value (5.62%) of the maximum dose difference of all the cases; the dose was represented as a 
percentage based on the total dose for this patient. The mean of the maximum dose difference 
was 2.98% for all tilted plans, and the maximum dose difference ranged from 0.03 to 5.62%. 
The mean value for the 1.5-degree tilted plans was 2.73%, and that for the 3-degree tilted 
plans was 3.22%. The maximum dose difference values for the 1.5-degree tilted plans for all 
cases did not exceed 4%. The maximum dose difference values for the 3-degree tilted plan for 
five cases (62.5%) did not exceed 4%, and only one case had ˃5%. The location of the 
maximum dose difference was around the PTV.  
 Absolute differences in the HI and D95 for the PTV (∆HI and ∆D95, respectively) and 
the D2ml, V50, V60, and V70 for the rectum (∆D2ml, ∆V50, ∆V60, and ∆V70, respectively) for the 
tilted plan were calculated from these values for the original plan. No correlation was found 
between the ∆HI, ∆D95, ∆D2ml, ∆V50, ∆V60, and ∆V70 and the maximum dose difference (Fig. 





There were no appreciable differences in dose distribution between the tilted and original 
treatment plans. The mean value of the maximum dose difference was only 2.98%, and even 
for the 3-degree tilted plans it was only 3.22%. This value is similar to the dose variance of 
3% obtained with use of the Monte Carlo dose calculation. 
Regarding all of the dose and volume indexes for all structures, there were no 
significant differences among the tilted and original plans. However, there was a trend for 
increasing values of the HI for the PTV, and a trend for decreasing values for the PTV D95 
and the rectum D2ml. Differences regarding the PTV D95 and rectum D2ml between the 
±3-degree tilted plans were 0.70% and 0.71%, respectively. The HI was calculated from the 
D2, D98, and D50. The D50 was almost equal to the Dmed. Values for the Dmed and D2 for the 
PTV did not change with the pitch angle. Thus, the D98, which was close to the D95, affected 
the HI for the PTV.  
 There was a trend for decreasing values of the V50, V60, and V70 for the rectum. The 
difference between the mean values for the ±3-degree tilted plans for the V50, V60, and V70 
was approximately 1.8 ml. The mean volume of the rectum was 47.2 ml, and thus this 1.8 ml 
difference represents approximately 4% of the rectal volume. The RTOG-0415 study [18] 
applied a dose limit for the rectum that, for the V70, should not exceed 25% of the volume. 
Fiorino et al. [19] found that, if V70 was <30%, the frequency of late rectal bleeding decreased 
significantly. The range of V70 values for the rectum in the original plans in the present study 
was 2.9–7.7 ml (8.2–18.2%), and these values were lower than the RTOG-0415 dose limit 
even if the volume of 4% was added to the V70. 
Absolute differences in the HI and D95 for the PTV and the D2ml, V50, V60, and V70 for 
the rectum between the tilted and original plans had no correlation with the maximum dose 
difference (Fig. 8). The best correlation coefficient was -0.227 for the PTV ∆HI. Thus, a 
 13 
 
change in the dose distribution regarding the pitch angle error would not be associated with a 
trend for changing values of these indexes.  
The reason why the values for the dose and volume indexes for the PTV and the 
rectum tended to change according to the pitch angle error is that the PTV and rectum moved 
into low- or high-dose areas in the irradiation field, where the overall dose distribution 
remained almost unchanged at different pitch angles. The trend of these indexes might depend 
on the PTV margin. If a large PTV margin is applied, the radiation dose to the PTV will 
remain unchanged by the pitch rotation, but there will be a greater variation in the radiation 
dose to the rectum. The maximum dose difference might depend upon the PTV margin 
because the cases involving a large PTV (>100 ml) had a higher maximum dose difference 
than did the cases involving a small PTV (<100 ml); the mean values were 3.49% and 2.77%, 
respectively.  
The width of the PTV margin used could affect the results. If a PTV margin includes 
the effect of the rotational setup error the variation of the dose and volume indexes would be 
reduced. However, the calculation of the margin for rotational setup errors is very 
complicated, and the width of the margin would be varied according to the distance from an 
isocenter. TPSs could not automatically add such a non-uniform margin to a target, so that a 
planer should do time-consuming task to add the non-uniform margin. Many institutions 
ignore the rotational variation for the calculation of the PTV margin [13], so that evaluation of 
the impact of the rotational setup error is still important.    
 In image-guided radiation therapy, cone beam computed tomography can reveal the 
prostate, or two-field radiography can detect the position of the prostate and its angle by 
detecting implanted fiducial markers such as gold coils. In image-guided radiation therapy, it 
is also possible to use cone beam computed tomography images of the prostate or the fiducial 
markers to calculate the setup error, instead of the bony anatomy. The setup error calculated 
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from prostate images often differs from that calculated by means of the bony anatomy. Body 
leaning of ±3 degrees only makes about a 3% difference at most in the dose distribution in the 
patient’s body. In addition, the HI and D95 for the PTV and the D2ml, V50, V60, and V70 for the 
rectum showed that a portion of the prostate or rectum may move into a low- or high-dose 
area if the setup error is corrected according to the angle calculated from the bony anatomy. 
Thus, a setup error correction should be carried out in accordance with the angle of organs 
such as the prostate and rectum in VMAT for prostate cancer. 
 In the present study, shifting of the body was performed in the CT images instead of 
true rotation of the body. There is a difference between rotated and shifted positions along the 
SI direction; this is particularly true regarding the anterior/posterior portion of the body in the 
isocenter slice. The anterior/posterior portion of the body can have the largest SI positional 
differences. The difference depends on the rotational angle and the distance from the isocenter, 
which is the origin of the rotation. The rectum and prostate are shown in the isocenter slice, 
but the rectum is farther from the isocenter. The mean distance from the isocenter to the 
anterior rectum wall along the AP direction, to which a higher dose was delivered, was 15.7 
mm (all cases). When the body rotation was 3 degrees, the anterior rectum wall (15.7 mm 
from the isocenter) should be shifted by 0.8 mm along the SI direction. The rectum is long in 
the SI direction, so that the dose that should be delivered to the rectum in the isocenter plane 
would be delivered to that in the next slice. Additionally, the difference of 0.8 mm was about 
a quarter of the calculation grid size (3 mm). Therefore, the dose and volume indexes for the 
rectum were not appreciably affected by the positional difference in the SI direction around 
the isocenter slice. The dose and volume indexes for the rectum would be affected mainly by 
the positional variations along the AP direction in slices near the field boundaries.  
      Regarding the positional difference between the truly rotated and shifted distal 
portions of the body, the positional difference could be larger than that for the rectum. The 
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distal portion of the body should be replaced by a portion of the body in other slices, or 
interpolated with a portion in other slices if the body was truly rotated. However, such a 
portion is mainly soft tissue, and the portion in other slices is usually the same tissue, so that 
the difference at the distal portions did not affect the dose distribution. Only the sacrum bone 
would have an effect on the dose distribution because it is located near the back and its distal 
end would be located in the irradiation field. The mean distance between the sacrum bone and 
the isocenter was about 70 mm along the AP direction. The distance of 70 mm caused a 3.7 
mm difference in the SI direction when the rotation angle was 3 degrees. This difference is 
larger than the calculation grid size. Thus, our results could not include the effect of this 
displacement of a sacrum bone. For portions located far from the isocenter along the SI 
direction, these portions mainly move up/down when the body is rotated. Shifting the body in 
CT images does not cause a large error.  
The rectum and prostate can be deformed by the volume of gas and feces in the rectum. 
The bladder can also be deformed, depending on the amount of urine present. With our 
method, we cannot evaluate the effects of these organ deformations because it uses only one 
CT image set for radiotherapy planning and we investigated the impact of body rotation. The 
dose to the rectum might be changed by the deformation even if the prostate position and 
rotation is corrected by use of a 6 degrees-of-freedom robotic couch. For instance, if the 
volume of feces in the rectum increases from at the radiation therapy planning, the volume of 
the rectum wall receiving a high dose will be reduced because the rectum wall is expanded. 
This is a favorable example but to obtain such impact and also avoid unfavorable impact, 
doses to the prostate and surrounding tissue should be delivered as originally planned. 
According to our findings, moving a portion of an organ into a higher/lower-dose area as a 
result of organ motion affected dose to the organ, so that the setup error correction 
corresponding to the motion of the prostate should be applied. The dosimetric impact of organ 
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deformation depends upon cases. Assessment of the general dosimetric impact of organ 
deformation is difficult because quantification or categorization of organ deformation is not 
easy. However, correction of the setup error according to prostate motion by use of a 6 
degrees-of-freedom couch might minimize the impact of deformation.    
 
5. CONCLUSION 
The mean value of the maximum dose differences between the original VMAT plan and the 
tilted one was about only 3%. The value of the HI for the PTV had an increasing trend 
according to the pitch angle error, and the values of the D95 for the PTV and D2ml, V50, V60, 
and V70 for the rectum had decreasing trends. However, there was no correlation between 
these indexes and the maximum dose difference. Body leaning caused by the pitch angle error 
correction had little effect on the dose distribution; in contrast, the pitch angle correction can 
reduce the effects of organ displacement and improve the dose and volume indexes. Thus, the 
pitch angle setup error in VMAT for prostate cancer should be corrected with the pitch angle 
error of the prostate. 
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Fig. 1. Illustration showing pitch angle directions. 
 
Fig. 2. CT image set with a virtual pitch angle error. The original position of the body is 
indicated by dashed lines in slices a and c. The body in the images was shifted by the 
distances d1 and d2; they depend on the angle θ  and the distance from a slice that includes 
the isocenter. 
 
Fig. 3 Dose indexes for CTV 
Circles in the graphs show the values for the case in each index, boxes indicate the range of 
the standard deviation for the values, and bars represent the maximum and minimum values. 
All of the dose indexes had no significance by the Kruskal–Wallis test and the 
Jonckheere–Terpstra test. 
  
Fig. 4 Dose indexes for PTV 
Circles in the graphs show the values for the cases, boxes indicate the range of the standard 
deviation for the values, and bars represent the maximum and minimum values. All of the 
dose and volume indexes had no significant difference by the Kruskal–Wallis test, but the D95 
and the HI had significant trends as tested by the Jonckheere–Terpstra test (p<0.05). 
 
Fig. 5 Dose and volume indexes for bladder 
Circles in the graphs show the values for the cases in each index, boxes indicate the range of 
the standard deviation for the values, and bars represent the maximum and minimum values. 





Fig. 6 Dose and volume indexes for rectum 
Circles in the graphs show the valuse for the cases in each index, boxes indicate the range of 
the standard deviation for the values, and bars represent the maximum and minimum values. 
All of the dose and volume indexes had no significant difference by the Kruskal–Wallis test, 
but the D2ml, V50, the V60, and the V70 had significant trends as tested by the 
Jonckheere–Terpstra test (p<0.05). 
 
Fig. 7. Example of subtracted dose overlaying on the CT image. The dose differences between 
the dose distributions on the original plan and the -3 degrees tilted one are shown. This case 
has the largest value of the maximum dose difference (5.62%; white arrow) of all the cases, 
and the location of the largest difference is around the PTV (white triangles). The anterior and 
posterior skin areas (top and bottom of the body in the CT image) represent large differences 
between the dose to tissue and the dose to air because of the body tilt. The skin area was 
excluded from the calculation of the maximum dose difference in the CT images.  
 
 
Fig. 8. Graphs showing the correlation between the maximum dose difference, and the dose 
and volume indexes whose values were dependent on the pitch angle. Graph (a) shows the 
correlation between the maximum dose difference and the absolute value of the PTV
95DD . 
Graph (b) shows the correlation between the maximum dose difference and the absolute value 
of the PTV ∆HI. Graph (c) shows the correlation between the maximum dose difference and 
the absolute value of the ∆D2ml for the rectum. Graph (d) shows the correlation between the 
maximum dose difference and absolute value of the ∆V50, ∆ V60, ∆ V70 for the rectum. 
 








